XML 16 R6.htm IDEA: XBRL DOCUMENT v3.23.1
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
shares in Thousands, $ in Thousands
Common Stock
Additional Paid-in Capital
Treasury Stock, At Cost
Notes Receivable From Stockholders
Accumulated Other Comprehensive Loss
Accumulated Deficit
Total
Balance at beginning of period at Jun. 30, 2021 $ 31 $ 378,451   $ (92) $ (1,220) $ (331,109) $ 46,061
Balance at beginning of period (in shares) at Jun. 30, 2021 31,231            
Interest on stockholders' notes       (3)     (3)
Issuance of common stock upon exercise of stock options   2,042         2,042
Issuance of common stock upon exercise of stock options (in shares) 525            
Issuance of common stock in connection with employee stock purchase plan   558         558
Issuance of common stock in connection with employee stock purchase plan (in shares) 65            
Stock-based compensation   8,936         8,936
Foreign currency translation adjustments         (445)   (445)
Net loss           (890) (890)
Balance at end of period at Mar. 31, 2022 $ 31 389,987   (95) (1,665) (331,999) 56,259
Balance at end of period (in shares) at Mar. 31, 2022 31,821            
Balance at beginning of period at Dec. 31, 2021 $ 31 385,467   (94) (1,356) (331,384) 52,664
Balance at beginning of period (in shares) at Dec. 31, 2021 31,493            
Interest on stockholders' notes       (1)     (1)
Issuance of common stock upon exercise of stock options   1,512         1,512
Issuance of common stock upon exercise of stock options (in shares) 328            
Stock-based compensation   3,008         3,008
Foreign currency translation adjustments         (309)   (309)
Net loss           (615) (615)
Balance at end of period at Mar. 31, 2022 $ 31 389,987   (95) (1,665) (331,999) $ 56,259
Balance at end of period (in shares) at Mar. 31, 2022 31,821            
Repurchase of common stock, shares             0
Balance at beginning of period at Jun. 30, 2022 $ 32 393,157   (95) (2,687) (333,550) $ 56,857
Balance at beginning of period (in shares) at Jun. 30, 2022 31,930            
Interest on stockholders' notes       (1)     (1)
Issuance of common stock upon exercise of stock options   568         568
Issuance of common stock upon exercise of stock options (in shares) 165            
Repurchase of common stock     $ (1,101)       (1,101)
Issuance of common stock in connection with employee stock purchase plan   540         540
Issuance of common stock in connection with employee stock purchase plan (in shares) 72            
Stock-based compensation   5,283         5,283
Foreign currency translation adjustments         186   186
Net loss           (492) (492)
Balance at end of period at Mar. 31, 2023 $ 32 399,548 $ (1,101) (96) (2,501) (334,042) 61,840
Balance at end of period (in shares) at Mar. 31, 2023 32,022   145        
Balance at beginning of period at Dec. 31, 2022 $ 32 397,998   (96) (2,893) (333,670) 61,371
Balance at beginning of period (in shares) at Dec. 31, 2022 32,131            
Issuance of common stock upon exercise of stock options   103         103
Issuance of common stock upon exercise of stock options (in shares) 36            
Repurchase of common stock     $ (1,101)       (1,101)
Stock-based compensation   1,447         1,447
Foreign currency translation adjustments         392   392
Net loss           (372) (372)
Balance at end of period at Mar. 31, 2023 $ 32 $ 399,548 $ (1,101) $ (96) $ (2,501) $ (334,042) $ 61,840
Balance at end of period (in shares) at Mar. 31, 2023 32,022   145        
Repurchase of common stock, shares (145)   145       (145)